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To the Editors: 
We read with interest the letter to the editor by Cav- 
allari and associates regarding endothelial and smooth 
muscle cell preservation i veins with University of Wis- 
consin solution (UWS). Our observation that venous 
endothelium and smooth muscle cells were preserved 
inadequately with UWS 1 was in contrast with the findings 
of Cavallari et al.2, 3 They did not observe a detrimental 
effect of UWS on endothelial and smooth muscle func- 
tion, and they suggested that we found detrimental effects 
because our control tissue was stored for 1 hour. We do 
not agree. Our control tissue responded normally to the 
various agonists as regards the ability to relax and contract 
after a 1-hour incubation period compared with fresh 
saphenous vein tissue. We believe that the tissue, as a con- 
trol, should be exposed to the same incubation time as the 
UWS to accurately compare the responses of both tissues. 
These two studies once again highlight he complex inter- 
actions caused by UWS on the different components of 
the vascular wall and document differences between ves- 
sels from different species. Further work clearly is required 
to understand the interaction of UWS and its possible use 
as a preservation solution for saphenous vein bypass grafts. 
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Regarding "Prospective randomized trials of  carotid 
endarterectomy with pr imary closure and patch 
reconstruction: The problem is power" 
To the Editors: 
We read with interest the results of Dr. Archie's infor- 
mal meta-analysis of the trials of patch angioplasty versus 
primary closure in carotid endarterectomy (J Vasc Surg 
1997;25:1118-9), which he thought provided compelling 
evidence in favor of patching. As part of the Cochrane 
Collaboration Stroke Group, 1 we have produced a formal 
meta-analysis of these trials that we update as new trials 
are published. 2 At least seven relevant rials have been 
published. When we added the preliminary results of the 
trial by AbuRahma et al. (J Vasc Surg 1996;24:998-1007) 
to our previous meta-analysis, we found results that were 
similar to the results from Archie. Patching reduced the 
risk of any stroke within 30 days of surgery by two thirds 
when compared with the primary closure group (1.5% vs 
4.5%, two-tailed p = 0.004) and also reduced the risk of 
any stroke or death within 30 days (2.2% vs 5.2%, two- 
tailed p = 0.007) and the risk of early arterial occlusion 
(0.5% vs 3.9%, two-tailed p < 0.0001). These benefits 
apparently were maintained for several years. 2
However, although we agree that these results are 
promising, we do not believe that they are compelling for 
three reasons. First, the trials were generally of poor qual- 
ity and may have biased the findings in favor of patching. 2 
Only three trials definitely used adequate methods of ran- 
domization that prevent selection bias. 3 In at least four 
trials the clinical outcomes were not assessed as blind to 
treatment allocation, and so the assessment of  minor 
strokes or ultrasound results may have been biased. All 
trials randomized carotid arteries rather than patients, 
and therefore 5% to 10% of patients underwent bilateral 
procedures. In these patients, the events in the two arter- 
ies are not independent, and so standard statistical naly- 
sis is not appropriate 4 In addition, if a patient underwent 
simultaneous bilateral operations and then died or had a 
stroke, the particular procedure that was responsible for 
the event may be difficult to ascertain. Approximately 5% 
JOURNAL OF VASCULAR SURGERY 
Volume 27, Number 2 Letters to the Editor 387 
of the patients who were initially randomized were 
excluded from the final analysis, which may also have 
biased the results. 
Second, the results are derived from a small number of 
outcome vents, and therefore any of the above potential 
biases may have had a major effect on the overall findings. 
For example, only 29 perioperative strokes and 23 arterial 
occlusions were in all of the trials combined. 
Third, we have not included any unpublished trials, 
and so publication bias may have overestimated the effects 
of patching because unpublished trials tend to have nega- 
tive results. 5 
We believe that more data are required before routine 
patching can be recommended. Because bias may have 
exaggerated the benefits of patching in the present meta- 
analysis, a more realistic view would be that patching 
could reduce the risk of stroke or death within 30 days of 
surgery by 50%, from 5% to 2.5%. This benefit would still 
be worthwhile. However, a trial, or a meta-analysis of 
small high-quality trials, would be required of nearly 3000 
patients to have a 90% chance of detecting such a benefit 
reliably. Because only 1100 patients have been included in 
trials to date, we think further better-designed trials that 
compare patching with primary closure are required. 
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Regarding "Secondary aortoesophageal fistula" 
To the Editors: 
The recent report by Pipinos and Reddy (J Vasc Surg 
1997;26:144-9) described successful surgical treatment of 
an aortoesophageal fistula that occurred 14 months after 
thoracoabdominal aortic aneurysm repair. The subsequent 
review of the literature lists 15 previous cases of fatal sec- 
ondary aortoesophageal fistulae; no survivors are identi- 
fied. Although the authors are to be commended for suc- 
cessfully managing this catastrophic problem, the first 
report that described survival after repair of a secondary 
aortoesophageal fistula deserves recognition. Nearly 30 
years ago, Yonago et al. 1 reported a case that involved a 
44-year-old woman with dysphagia caused by a fight aor- 
tic arch with aberrant left subclavian artery. During divi- 
sion of the aortic ring, the ectatic diverticulum of Kom- 
merell was injured and required primary repair. One 
month after the operation, the patient returned with a her- 
aid bleed that was followed by massive hematemesis 2 days 
later; thoracic pain and signs of infection were not 
described. An emergent thoracotomy revealed "a false 
aneurysm of the aorta and an aortoesophageal fistula at 
the site of the previous aortic repair." The esophagus and 
aorta both were repaired primarily and covered with pedi- 
cled pleural flaps. The patient subsequently had sepsis and 
hematemesis that were caused by a recurrent fistula. The 
fistula was managed by placing an extraanatomic bypass 
graft with a Dacron graft from the ascending aorta to the 
distal descending thoracic aorta that was followed by 
resection of the involved aortic segment and by a layered 
primary esophageal repair that was reinforced with adja- 
cent tissues. After a complicated postoperative course, the 
patient recovered and was asymptomatic 15 months after 
the initial operation. 
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To the Editors: 
We would like to thank Dr. LeMaire for bringing the 
report by Yonago et al.1 to the attention of the vascular 
scientific community. In 1969 Dr. Yonago reported a 
potentially original case of  successful repair of  a fistula 
between a previously suture-repaired aorta and the adja- 
cent esophagus. 
The secondary aortoesophageal fistu a is the rarest 
type of aortopeptic fistula. Our understanding of the 
pathogenesis and the optimal management of this entity 
remains limited. Our group has maintained an active inter- 
est in the primary and secondary communications between 
